Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Momentum forward
View:
Post by CarbonWarrior on Nov 24, 2022 12:47pm

Momentum forward

Goblet caught the market attention. 

Now, we move on with real strong momentum. This baby could shoot up to 6$ shortly, then 10$ as we get closer to deal day!
Comment by Angler101 on Nov 24, 2022 1:08pm
No barking dogs in almost 24 hours! .....I miss their constant daily rants that are both funny and also confirmations of the growing interest in this stock.....maybe shorts are getting nervous and finally covering their positions......
Comment by m00nsh0ts on Nov 24, 2022 1:16pm
The barking dogs are probably US-based and they're off today.
Comment by Angler101 on Nov 24, 2022 1:22pm
Oh yeah........right.....lol
Comment by canadafan on Nov 24, 2022 1:47pm
The barking dogs are a team of bashers. Posting under various handles, under a few chat boards like SH. I have yet to figure out their motivation? Shorting, or trying to buyin lower, or part of a larger scheme. Few realize that once MBc phase 3 enrolment starts, the China partner is entitled to about $18million in warrants. Price being 120% of the trailing SP average. What better motivation to ...more  
Comment by inthno on Nov 24, 2022 2:10pm
The constant bashing makes no sense, frustration in the sp and pace of things I can understand. I am really hoping that we do not have to wait until Bracelet for a partner or buyout as it is still an unknown. There is really not enough short out there for anyone to worry about IMO and no hedge funds trying to accumulate as some suggest. It will be interesting to see what AN has to say in regards ...more  
Comment by Angler101 on Nov 24, 2022 2:22pm
Regardless of who the dogs are, where they come from, who they work for, or whether they work for someone else, their prime, sole intent here is to buy more shares at the cheapest price possible. 
Comment by Hcallahan44 on Nov 24, 2022 3:03pm
Yea thats it angler....i want more toilet paper....i already have 62000 rolls......
Comment by Angler101 on Nov 24, 2022 3:24pm
In your case, that’s certainly a good thing.
Comment by Buckhenry on Nov 24, 2022 3:45pm
I like how some folks on here think they have everyone and everything figured out here. I hope this does get bought out soon so I don't have to continually exposed your factless pumping. im a realist and deal in facts. we will know something when the company decides to tell us. its you pumping speculators that are misleading everyone. blue skies!!!
Comment by Quentin30 on Nov 24, 2022 3:48pm
at this stage, I don't think a partnership will significantly move the dial, pps wise. A buyout would be better. But what premium is any company going to offer over current ONCY pps. x2, x3..? The 8 billion price tag touted by Noteable, is what, 80 times the current price... THINK..!!! REALLY ? With only a partnership in hand, we will be sat waiting another 4 years minimum before approval ...more  
Comment by Hcallahan44 on Nov 24, 2022 3:01pm
oh god....few REALIZE now?????  plenty realize....and plenty are not interested....i know it appears irrational to own the stock as i do with 62000 share currently.....but at this point i look at this as sunk cost i will never get back....so if i can keep a few newbies from sinking their money into Coffey's candy machine i will hope for some spiritual rewards.....for those new here i ...more  
Comment by Quentin30 on Nov 24, 2022 3:41pm
These so called barking dogs, ask questions, that pumpers like you always sidestep. Canadafan for years you have been touting this company. And you have been wrong in your predictions of price increase 90% of the time. The value of this company is having included as a part of a combination therapy. If it doubles the potential sales of the CPI owner, and that CPI owner wants to secure ONCY for ...more  
Comment by Angler101 on Nov 24, 2022 3:50pm
Quentin.....If that was your version of a technical analysis, I gotta say thanks......that was the best chuckle I’ve had from your posting in quite a while....a 12 year old could’ve something more convincing.
Comment by CarbonWarrior on Nov 24, 2022 4:11pm
Plenty of people lost plenty of Money Elon twitter fiasco =44Billions Zuckerburg = -85 Billion Meta madness Crypto implosion... But but but there is still plenty of people that have money for a speculative bet. ONCY is nice to look at. Place your bet here and ride it up to 6$. This is the best play in around for a nice return. You got two big pharma waiting to make an offer Awesome data ...more  
Comment by Buckhenry on Nov 24, 2022 4:16pm
I hope ur right but you can't prove any of this... its puuuuure speculation. this is the same garbage we have been hearing from the pumping squad since god was a pup. 
Comment by Quentin30 on Nov 24, 2022 4:18pm
and that cash was reported as of June in the most up to date presentation... which means, unless they have been at the ATM... we're needing to top up, as we need to have 12 months cash in hand to fund operations. the dilution is killing longer term holders... 
Comment by Quentin30 on Nov 24, 2022 4:15pm
and you have provided..??? oh yeah, nada... just another rose tinted spectator, cheering on the unicorn hunters.... to the moon... to the moon...  how do you value ONCY, and get a figure for future sales/royalties.. we'd love to know.
Comment by westcoast1000 on Nov 24, 2022 5:00pm
Quentin is a negative spinner. It is not our job to precisely figure out future revenues here. The current price of the stock is something like 3-4 times cash. It is so wildly off of anything like an expected value of the company that it is beyond absurd We have intellectual property that could well lead to P3 trials and product approvals in two major unmet cancer indications. We can partner ...more  
Comment by Buckhenry on Nov 24, 2022 5:02pm
we ALL have our own spin on this stock... respect or move on. 
Comment by inthno on Nov 24, 2022 7:02pm
Hello Westcoast and I agree way too much negativity. I do have a concern which I have tried to bring up before and would like your thoughts. You said....We have intellectual property that could well lead to P3 trials and product approvals in two major unmet cancer indications. We can partner with a whole array of other I/O products, for which we can wildly improve their efficacy. My condern with ...more  
Comment by Noteable on Nov 24, 2022 7:42pm
Why file for any further IP when ONCY's manufacturing IP is valid and extendable to 2034 and the FDA's provision on innovative biological products provides 12 years marketing exclusivity on novel biologics from the date the product is granted marketing approval. Should ONCY's acquirer decide on further patent protection the acquirer will be able to file and be assigned the relative ...more  
Comment by inthno on Nov 24, 2022 8:09pm
Hey Noteable, I agree that it is extendable and that was not my point. I was simply stating that things need to get moved along quickly as they are only extendable upon fda approval and at the rate trials are taking to finish and then get fda approval that it is possible that the trial could not be finished and approved in the given timeframe as many of the trials with any number of patients seem ...more  
Comment by inthno on Nov 24, 2022 8:20pm
Yikes, I meant....I don't think anyone can DISAGREE with that so come on onc management, let's do a deal and get this done.
Comment by Noteable on Nov 24, 2022 9:13pm
No ... I don't think you understand the potential of pelareorep being granted an accelerated approval in pancreatic cancer for example notwithstanding that I have posted on how the process works on various occasions here. Such a condititional approval on favorable and OS data can be granted within months of a BLA accelerated approval submission and final approval when a post-approval Phase 3/4 ...more  
Comment by Noteable on Nov 24, 2022 9:24pm
Should read ...Such a condititional approval on favorable PFS and OS data can be granted within months of a BLA accelerated approval submission by a company should the drug demonstrate statistical improvement over SOC while also filling an unmet medical need at the same time. It seems that most doctors who have commented on ONCY'S Goblet pancreatic study results believe the same. A 69% ORR, a ...more  
Comment by inthno on Nov 24, 2022 9:29pm
a conditional approval would be amazing if that could happen. I understand the timelines quite well and would still prefer a buyout to remove all doubt. We never know which way things will go regarding fast track or conditional approval as this are all best case scenarios. Quite simple, not arguing, just saying I would prefer a buyout and finally be done after 22 years
Comment by Noteable on Nov 24, 2022 9:55pm
The desire for a buyout is mutually shared on this and other message boards.
Comment by Quentin30 on Nov 25, 2022 4:20pm
alas westcoast, I'm a long term shareholder, since 2004. Through trading the stock I've changed a 95% loss prior to release of IND-213 data, to what is now a 50% loss. And my core holding have occasionally been in the green... but usually only for a day or two... no stock runs are ever sustained. And NO,  I'm not here to bash... I'm here to question... and generate ...more  
Comment by canadafan on Nov 25, 2022 4:36pm
All of your questions are answered on the most recent " investor presentation" on the corporate web site. You seem to be looking for problems thst don't exist. They have ample cash to near end of 2023. Long before which ALL of the efficacy & need to use, questions will be answered. There are 3-4 analysts covering Onc. They all have the same consensus , a partnership going ...more  
Comment by inthno on Nov 25, 2022 5:22pm
Hello Canadafan, and rest assured I am on your side and want this to happen as much as anybody. Earlier in the year you said there were 3 analysts that said they all expected to have a partnership by the end of 2022 and I could not find the reports you were talking about. Now you are saying that 3-4 analyts are all saying we will have a partnership going into early 2023, Not trying to be a pain ...more  
Comment by westcoast1000 on Nov 25, 2022 6:14pm
inthno 11.22.22 Buy Reiterated PATRICK TRUCCHIO H.C. Wainwright 0.1 star rating                ...more  
Comment by Normandt on Nov 25, 2022 6:20pm
It's always been the game of Ithno (aka dreamer and many other user names) to sow doubt, ask suspicious questions, yet easy to find. He makes a good team with uber and company but acts like a snake.
Comment by inthno on Nov 25, 2022 6:37pm
Not a game Norm and why is it a suspicious question to ask for the quotes in regards to the 3-4 analysts that all say we will have a partnership early 2023. I will give you an example from what I post as this is a quote from the latest Leed Jones Report. Accordingly, we expect Oncolytics to be a partnered Phase III-stage oncology biologics developer no later than FH124." All I was looking ...more  
Comment by Normandt on Nov 25, 2022 6:52pm
Your long texts to say nothing tire me. I'll give you a short answer. For how many months several Oncy analysts have been giving a target price above $7. Do they set a target price for 2 years later according to you, ..... and this target price means of course that there will be a partnership for one or more phases 3 don't you think. Seek and you will find. End of the story with you.
Comment by inthno on Nov 25, 2022 6:58pm
You don't get it Norm, I want the partnerships or BO as much as anybody and think that we will have it. Also I am not saying it won't happen, I figure it will. And are you saying that you also do not have the analysts that say we will have a partnership early 2023? How hard is it to provide that information if someone says it will happen. My god you people, I was not even being ...more  
Comment by Buckhenry on Nov 25, 2022 9:34pm
lol...love it... wainwright gave a price target several years ago and has no credibility. most folks on here are looking for something to sink their teeth into or have mommy tell them... it will be ok.  its just a wait and see game and has been for quite some time. but I do love to read the posts from those know it alls here
Comment by inthno on Nov 25, 2022 6:29pm
westcoast, I think you should know me better than this as when I post information it is always with the quotes from either the pr or whatever report it was from. All I was asking is to have the quotes or information where it said 3-4 analysts all say that we should have a partnership early 2023. That was not an unreasonable request. I and everyone already know we have analysts following the ...more  
Comment by Buckhenry on Nov 25, 2022 6:54pm
I get tickled reading all these posts like you folks have it all figured out.  most of you folks are a legend in your own mind.  I will just wait for official information and continue to laugh at 95% of the posts on here. 
Comment by canadafan on Nov 25, 2022 8:17pm
From RBC report: Valuation Our $6.00 rounded price target is based on a blend of our DCF and 2030E P/E valuations. Our DCF at 20% yields a $5.21/sh valuation, and 15.0x 2027E Adj. EPS, discounted back at 20%, equates to $6.69/sh. Our discount rate and P/E multiple are relatively in line with valuations for development-stage oncology companies. We assume late-2024 FDA and EU approval ...more  
Comment by inthno on Nov 25, 2022 8:31pm
Many thanks Canadafan as that is all I needed and want to add it to the information that I have. It also gives me more assurances of what I am hoping will happen all before the AGM if all the cards lay out for us.
Comment by canadafan on Nov 25, 2022 8:35pm
here is the link. It may or may not work https://www.rbcinsight.com/WM/ResearchViewer/1924-656701-1/1654?docType=PDF&
Comment by inthno on Nov 25, 2022 8:41pm
appreciate the link although it did not work as it said user must be logged in but I am good with the information that you provided and thanks again as I do not have access to many of these analyst reports unless someone posts them.
Comment by westcoast1000 on Nov 25, 2022 6:01pm
Quentin, You SOUND sincere but it is hard to take your comments seriously. Like this one: ." How do we (you) know how good the Bracelet-1 data is... if it is no better than that from IND-213, ONCY will have wasted 5 years and we still don't have a partner..." Quentin, you and I both know this Bracelet study was to broaden and verify the IND 213 data. We were told by potential ...more  
Comment by westcoast1000 on Nov 25, 2022 6:06pm
Should be: .......WITHOUT a partner and regulatory support.
Comment by Buckhenry on Nov 24, 2022 4:04pm
now lets be careful we don't ruffle the feathers of the pumpers on thanksgiving.  they don't like it when you disagree with their narrative and get down right hateful. I have had to take several here off of my Christmas card list this year and told Santa not to stop at their house. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities